AKESOgen is a biomarker, genomics and pharmacogenomics CRO company that services the academic, pharmaceutical, biotechnology and agricultural sectors. The company is based in Atlanta, GA, USA.
AKESOgen performs biomarker profiling and genomics services (e.g. next generation sequencing and genotyping) utilizing different types of markers (e.g. DNA, mRNA, miRNA, methylation) for the R&D market.
AKESOgen establishes and validates biomarkers in the Clinical Trials arena.
AKESOgen has expertise in Biobanking.
PRESS RELEASE: Cytox, a precision medicine testing company commercializing polygenic risk scoring (PRS) and other approaches for assessing genetic risk for developing Alzheimer's disease, has collaborated with integrated genomics and genetics leader...